Merck & Co. is no longer in talks to acquire biotech firm Revolution Medicines Inc. after the two companies couldn’t agree on ...

Merck & Company Inc (NYSE:MRK) has ceased discussions to acquire biotechnology firm Revolution Medicines Inc (NASDAQ:RVMD), following a failure to reach an agreement on the company’s valuation.

The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at ...

The pharmaceutical giant had been in talks to buy the cancer drug developer in a transaction that could have valued ...

Investors are apparently taking bets on when Revolution will be acquired. A handful of pharmas could be interested as Merck ...

Guardant Health is signing up to a multiyear deal with Merck & Co. for the U.S. Big Pharma to tap its Infinity Smart platform ...

Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

The company’s previous CCO was Cristal Downing, who joined Insulet as chief corporate affairs officer late last year.

Merck, a leading science and technology company, has opened its new $176 million filtration manufacturing facility at Blarney Business Park, Co. Cork. This site is Merck’s first manufacturing facility ...